ADAnna Deal

Anna Deal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anna Deal has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Defining indicators for disease burden, health outcomes, policies and barriers and facilitators to health services for migrant populations in the Middle East and North African region: a protocol for a suite of systematic reviews

    by Farah Seedat, Stella Evangelidou, Moudrick Abdellatifi, Oumnia Bouaddi, Alba Cuxart-Graell, Hassan Edries, Eman Elafef, Taha Maatoug, Anissa Ouahchi, Liv Mathilde Pampiri, et al.

    Introduction The Middle East and North African (MENA) region is characterised by high and complex migration flows, yet little is known about the health of migrant populations, their levels of underimmunisation and access to healthcare provision. Data are needed to support regional elimination and control targets for key diseases and the design and delivery of programmes to improve health outcomes in these groups. This protocol describes a suite of seven systematic reviews that aim to identify, appraise and synthesise the available evidence on the burden and health outcomes, policies and access (barriers and facilitators) related to these mobile populations in the region. Methods Seven systematic reviews will cover three questions to explore the: (1) burden and health outcomes, (2) policies and (3) healthcare barriers and facilitators for the following seven disease areas in migrants in the MENA region: tuberculosis, HIV and hepatitis B and C, malaria and neglected tropical diseases, diabetes, mental health, maternal and neonatal health, and vaccine-preventable diseases. We will search electronic databases for studies in any language (year 2000–2023), reference-check relevant publications and cross-check included studies with experts. We will search for grey literature by hand searching key databases and websites (including regional organisations and MoH websites) for country-specific guidelines and talking to our network of experts for local and regional reports and key datasets. We will assess the studies and policies for their quality using appropriate tools. We will meta-analyse the data by disease outcome if they are of sufficient volume and similarity. Where meta-analysis is not possible and where data are on policy or access, we will narratively synthesise the evidence using summary tables, figures and text. Dissemination We anticipate disseminating the findings through peer-reviewed publications, conferences and other formats relevant to all stakeholders. We are following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and protocols will be registered on International Prospective Register of Systematic Reviews.


  • Open Access

    Hepatitis B infection and immunity in migrant children and pregnant persons in Europe: a systematic review and meta-analysis

    by Carla Hobart, Julia M Pescarini, Laith Evans, Haleema S Adil, Shehzhore T Adil, Anna Deal, Jessica Carter, Philippa C Matthews, Sally Hargreaves, Nuria Sanchez Clemente

    Background: The WHO’s global hepatitis strategy aims to achieve viral hepatitis elimination by 2030. Migrant children and pregnant persons represent an important target group for prevention strategies. However, evidence on the burden of chronic hepatitis B (CHB) infection and the factors affecting its incidence is lacking. Methods: EMBASE, Global Health, Global Index Medicus, Web of Science and Medline were searched for articles in any language from 1 January 2012 to 8 June 2022. Studies reporting CHB prevalence, disease severity, complications and/or prevention strategies, including vaccination, prevention of vertical transmission and access to care/treatment for migrant children and pregnant migrants, were included. Pooled estimates of CHB prevalence and hepatitis B vaccination (HBV) coverage among migrant children were calculated using random effects meta-analysis. Findings: 42 studies were included, 27 relating to migrant children and 15 to pregnant migrants across 12 European countries, involving data from 64 773 migrants. Migrants had a higher incidence of CHB than host populations. Among children, the pooled prevalence of CHB was higher for unaccompanied minors (UAM) (5%, [95% CI: 3–7%]) compared to other child migrants, including internationally adopted children (IAC) and refugees (1%, [95% CI: 1–2%]). Region of origin was identified as a risk factor for CHB, with children from Africa and pregnant migrants from Africa, Eastern Europe and China at the highest risk. Pooled estimates of HBV vaccine coverage were lower among UAM (12%, [95% CI: 3–21%]) compared to other child migrants (50%, [95% CI: 37–63%]). Conclusion: A range of modifiable determinants of HBV prevalence in migrant children and pregnant persons were identified, including sub-optimal screening, prevention and continuum of care. There is a need to develop evidence-based approaches in hepatitis care for these groups, thereby contributing towards global viral hepatitis elimination goals.


  • Open Access

    The immune status of migrant populations in Europe and implications for vaccine-preventable disease control: a systematic review and meta-analysis

    by Zeinab Cherri, Karen Lau, Laura B Nellums, Jan Himmels, Anna Deal, Emma McGuire, Sandra Mounier-Jack, Marie Norredam, Alison Crawshaw, Jessica Carter, et al.

    Background: Ensuring vaccination coverage reaches established herd immunity thresholds (HITs) is the cornerstone of any vaccination programme. Diverse migrant populations in European countries have been associated with cases of vaccine-preventable diseases (VPDs) and outbreaks, yet it is not clear to what extent they are an under-immunized group. Methods: We did a systematic review and meta-analysis to synthesize peer-reviewed published primary research reporting data on the immune status of migrants in EU/EEA countries, the UK and Switzerland, calculating their pooled immunity coverage for measles, mumps, rubella and diphtheria using random-effects models. We searched on Web of Science, Embase, Global Health and MEDLINE (1 January 2000 to 10 June 2022), with no language restrictions. The protocol is registered with PROSPERO (CRD42018103666). Findings: Of 1103 abstracts screened, 62 met eligibility criteria, of which 39 were included in the meta-analysis. The meta-analysis included 75 089 migrants, predominantly from outside Europe. Pooled immunity coverage among migrant populations was well below the recommended HIT for diphtheria (n = 7, 57.4% [95% confidence interval (CI): 43.1–71.7%] I2 = 99% vs HIT 83–86%), measles (n = 21, 83.7% [95% CI: 79.2–88.2] I2 = 99% vs HIT 93–95%) and mumps (n = 8, 67.1% [95% CI: 50.6–83.6] I2 = 99% vs HIT 88–93%) and midway for rubella (n = 29, 85.6% [95% CI: 83.1–88.1%] I2 = 99% vs HIT 83–94%), with high heterogeneity across studies. Interpretation: Migrants in Europe are an under-immunized group for a range of important VPDs, with this study reinforcing the importance of engaging children, adolescents and adults in ‘catch-up’ vaccination initiatives on arrival for vaccines, doses and boosters they may have missed in their home countries. Co-designing strategies to strengthen catch-up vaccination across the life course in under-immunized groups is an important next step if we are to meet European and global targets for VPD elimination and control and ensure vaccine equity.


  • Open Access

    Navigating vaccination choices: The intersecting dynamics of institutional trust, belonging and message perception among Congolese migrants in the UK (A reflexive thematic analysis)

    by Alison F Crawshaw, Tushna Vandrevala, Felicity Knights, Anna Deal, Laura Muzinga Lutumba, Sarah Luti Nkembi, Lusau Mimi Kitoko, Caroline Hickey, Alice S Forster, Sally Hargreaves

    Background: The COVID-19 pandemic has disproportionately impacted intersectionally marginalised migrants, revealing systemic disparities in health outcomes and vaccine uptake. An in-depth understanding of the underlying social and structural factors influencing health behaviours is necessary to develop tailored interventions for migrants but has been seldom explored. Therefore, this qualitative study aimed to explore the contextual factors shaping COVID-19 vaccination decision-making among Congolese migrants in the UK. Methods: A community-based participatory research study was designed and led by a community-academic partnership in London, UK (2021–2022). Peer-led, semi-structured interviews were conducted in Lingala with 32 adult Congolese migrants and explored beliefs, perceptions and lived experiences of migration, healthcare and vaccination and the pandemic. Reflexive thematic analysis generated two themes and a model conceptualising the vaccination decision-making process was developed. Participants and community partners were financially compensated, and the study received ethical approval from the University of London ethics committee (REC: 2021.0128). Findings: Participants highlighted the incompatibility of lockdown restrictions with their communal culture, which intensified feelings of exclusion and alienation. Concerns about COVID-19 vaccination were attributed to safety and effectiveness, partly informed by experiences and legacies of discrimination and exploitation of Black Africans. Inequality in the pandemic response and COVID-19 outcomes heightened participants’ sense that their views and needs were being overlooked and government sources and information were perceived as coercive. Drawing on this data, our model depicts the interplay between institutional trust, belonging, and message perception which shaped participants’ vaccination decisions and led to (non-)engagement with COVID-19 vaccination. Conclusion: This research enhances understanding of how social and contextual factors may influence migrants’ engagement with health interventions. It underscores the necessity of partnering with migrant communities to understand their needs in context and co-design tailored interventions and inclusive messaging strategies which foster trust and belonging. Implementing systemic changes to address structural inequalities will be crucial to create an environment that supports engagement with health-protective behaviours and enhances health outcomes among migrant communities.


  • Open Access

    Experiences of catch-up vaccination among adult migrants in the UK: An in-depth interview study

    by A Deal, A F Crawshaw, M Salloum, S E Hayward, J Carter, S Mounier-Jack, A Majeed, S Hargreaves

    WHO's Immunization Agenda 2030 emphasises equitable access to vaccination across the life course, including migrants who may have missed childhood vaccinations due to disrupted healthcare systems or differing vaccination schedules. Uptake of adult catch-up vaccination is thought to be poor in the UK, but limited evidence exists to explain this. In-depth semi-structured interviews were carried out across two studies with different adult migrant populations on views and experiences around vaccination. Study 1 recruited those resident <10 years in the UK from a range of backgrounds (remote interviews, 09/2020-01/2022, REC2020.0058) and Study 2 (in-person, 01/2022-03/2022, REC2021.0128) engaged Congolese and Angolan migrants. Interviews were conducted in English, Lingala or French and were audio-recorded, transcribed, and analysed through qualitative content analysis in NVivo 12. 71 participants were interviewed (mean age 43.6 [SD:12.4], 69% female, mean 9.5 [SD:7] yrs in UK). Most reported having never been offered or asked about vaccination history in the UK. Participants more often reported being offered seasonal or selective vaccinations (flu [n = 20], travel-related [n = 8], pregnancy-related [pertussis, n = 7]) compared to catch-up vaccines (MMR (n = 3), DTP (n = 3)) in the UK. Generally, participants were not aware of catch-up vaccination but viewed it mostly positively. Concerns included side effects, barriers to attending primary care facilities, and vaccination fatigue. Trust was an important factor in vaccination decisions, and participants expressed varying levels of trust towards healthcare professionals’ recommendations and the NHS. There is a need to increase opportunities for catch-up vaccination in primary care by incentivisation of catch-up vaccination and education of healthcare professionals. Low trust and concerns around safety exist in some migrant groups, for which tailored information campaigns or community-led interventions could be developed. Key messages: • There is a need to increase opportunities for catch-up vaccination in primary care. • Low trust and concerns around safety exist in some migrant groups, for which tailored information campaigns or community-led interventions could be developed.

  • Open Access

    Ensuring health and wellbeing of Ukrainian refugees in the UK: the role of initial health assessments and local authority involvement

    by A Deal, K Lau, S Hargreaves

    Since the beginning of the crisis in Ukraine, local authorities in the UK have facilitated the resettlement of over 150,000 Ukrainian refugees (as of February 2023) to the country. In this presentation, Anna Deal will discuss a UK case study based on her recent research working closely with local authorities in London to conduct a health and wellbeing needs assessment, exploring the situation facing Ukrainians and other key nationality groups on arrival. This presentation will focus on identified health and social needs of Ukrainians and current healthcare provision, including initial health assessments and catch-up vaccination delivery, for Ukrainians on arrival and how this varies under different local authorities. It will conclude by summarising key challenges faced in delivery of services and recommendations and implications for improving service delivery, both in the UK and other European countries hosting Ukrainian refugees.

  • Open Access

    Uptake of flu vaccination in Denmark: A comparison between Danish and migrant populations, 2015-2021

    by A Deal, S E Hayward, K Langholz Kristensen, J Holm Petersen, P Valentiner-Branth, J S Friedland, S Hargreaves, M Norredam

    WHO's Immunisation Agenda 2030 emphasises vaccination across the life course, including among migrants who may be at-risk in terms of access and uptake. Despite availability of a vaccine, influenza remains a key contributor to winter excess mortality in Europe. We analysed national Danish Registry Data to determine how flu vaccine uptake varies by migration status. We carried out a retrospective cohort study (2015-2020) to determine flu vaccine uptake among migrants ≥65 years matched 1:6 on age and gender to Danish-born. We used a multivariate logistic regression model (in R v4.2.1), controlling for migrant status, time in Denmark and other socio-demographic variables (age, gender, nationality, urban/rural residence), to identify factors associated with uptake. 81,644 individuals were included in the analyses. The flu vaccine uptake across 6 flu seasons in Danish-born was 44.7%, compared with 34.7% in the migrants. Migrants were statistically significantly (OR:0.64; 95% CI:0.62-0.65) less likely to receive a flu vaccine across all seasons; the gap widened from 2015 (OR:0.76; 95% CI:0.72-0.80) to 2020 (OR:0.49; 95% CI:0.47-0.51). Those who arrived as family-reunified to Danish citizens (OR:0.51, 95% CI:0.45-0.58) or to immigrants (OR: 0.58, 95% CI:0.47-0.71) were statistically significantly less likely to receive the vaccine across the study period than asylum seekers and refugees. In 2015-2017 seasons, those residing in Denmark >10 years were more likely (2015 OR:2.06, 95% CI:1.56-2.73; 2016 OR:2.35, 95% CI:1.75-3.15); 2017 OR:1.92, 95% CI:1.41-2.61) to receive a vaccine than those more recently arrived. Our data show that flu vaccine uptake was poor in all groups but that migrant groups have consistently lower uptake rates, particularly among family-reunified migrants and those more recently arrived. Migrant flu vaccination rates in migrants fell over a 6-year period. Going forward, developing tailored interventions in collaboration with communities will be key. Key messages: • Migrant groups have consistently lower uptake rates of flu vaccination than Danish born. • Newly arrived migrants are significantly less likely to get vaccinated, suggested targeted interventions may be needed.

  • Open Access

    Precarity, agency and trust: vaccination decision-making in the context of the UK asylum system

    by A Deal, M Salloum, S E Hayward, A F Crawshaw, J Carter, S Mounier-Jack, S Hargreaves

    Those living in initial asylum accommodation are at increased risk of vaccine-preventable disease, yet confidence in vaccination may be low. We aimed to understand vaccine confidence and decision-making among those going through the UK asylum system from a sociological perspective. In-depth semi-structured interviews were done on views and experiences around vaccination (09/2020-08/2021) with asylum seekers or those recently granted asylum (<10 yrs in UK). Interviews were conducted remotely, audio-recorded, transcribed and analysed through reflexive thematic analysis in NVivo 12. 25 participants were interviewed (mean age 37 years [SD:7], mean time in UK 6 years [SD:3], 72% female), of whom 13 were living in asylum accommodation at the time of interview. Preliminary analysis has indicated candidate themes relating to trauma, social isolation, agency and precarity running through discussions around vaccination decisions. Past trauma, such as discrimination at healthcare facilities or feeling forced to receive vaccinations in asylum accommodation, often directly impact trust and decisions to reject future vaccination. Participants described how their struggle for basic necessities, social isolation and precarious living situations imposed by the asylum system left them with other priorities than vaccination. Participants who perceived they have been well cared for in the healthcare system or who described feeling empowered to make their own decision about vaccination often suggested they would be likely to accept vaccination if offered. Asylum seekers and refugees have often experienced substantial trauma, precarity and have a lack of agency directly imposed on them by the asylum system, which are likely to impact trust and decision-making around healthcare. Formative experiences in the UK are key to establishing trust; a trauma-informed approach should be central in developing vaccination interventions for these groups, particularly in asylum accommodation. Key messages: • Trauma, precarity and lack of agency imposed by asylum systems are likely to impact trust and decision-making around healthcare. • A trauma-informed approach should be central in developing vaccination interventions for asylum seeking and refugee groups, particularly in initial accommodation settings.

  • Open Access

    Defining drivers of under-immunization and vaccine hesitancy in refugee and migrant populations

    by Anna Deal, Alison F Crawshaw, Jessica Carter, Felicity Knights, Michiyo Iwami, Mohammad Darwish, Rifat Hossain, Palmira Immordino, Kanokporn Kaojaroen, Santino Severoni, et al.

    Some refugee and migrant populations globally showed lower uptake of COVID-19 vaccines and are also considered to be an under-immunized group for routine vaccinations. These communities may experience a range of barriers to vaccination systems, yet there is a need to better explore drivers of under-immunization and vaccine hesitancy in these mobile groups. We did a global rapid review to explore drivers of under-immunization and vaccine hesitancy to define strategies to strengthen both COVID-19 and routine vaccination uptake, searching MEDLINE, Embase, Global Health PsycINFO and grey literature. Qualitative data were analysed thematically to identify drivers of under-immunization and vaccine hesitancy, and then categorized using the ‘Increasing Vaccination Model’. Sixty-three papers were included, reporting data on diverse population groups, including refugees, asylum seekers, labour migrants and undocumented migrants in 22 countries. Drivers of under-immunization and vaccine hesitancy pertaining to a wide range of vaccines were covered, including COVID-19 (n = 27), human papillomavirus (13), measles or Measles-mumps-rubella (MMR) (3), influenza (3), tetanus (1) and vaccination in general. We found a range of factors driving under-immunization and hesitancy in refugee and migrant groups, including unique awareness and access factors that need to be better considered in policy and service delivery. Acceptability of vaccination was often deeply rooted in social and historical context and influenced by personal risk perception. These findings hold direct relevance to current efforts to ensure high levels of global coverage for a range of vaccines and to ensure that marginalized refugee and migrant populations are included in the national vaccination plans of low-, middle- and high-income countries. We found a stark lack of research from low- and middle-income and humanitarian contexts on vaccination in mobile groups. This needs to be urgently rectified if we are to design and deliver effective programmes that ensure high coverage for COVID-19 and routine vaccinations.


  • Open Access

    Co-designing a theory-informed, multi-component intervention to increase vaccine uptake with Congolese migrants: a qualitative, community-based participatory research study

    by Alison F Crawshaw, Lusau Mimi Kitoko, Sarah Nkembi, Laura Muzinga Lutumba, Caroline Hickey, Anna Deal, Jessica Carter, Felicity Knights, Tushna Vandrevala, Alice S Forster, et al.

    Introduction Inequitable uptake of routine and COVID-19 vaccinations has been documented among intersectionally marginalised populations, including migrants, and attributed to issues of mistrust, access, and low vaccine confidence. Novel approaches which seek to share power, build trust and co-design tailored interventions with marginalised or underserved communities must be explored, to promote equitable engagement with vaccination and other health interventions. Methods A theory-informed, qualitative, community-based participatory research study, designed and led by a community-academic partnership, which aimed to understand decision-making related to COVID-19 vaccination among Congolese migrants in the UK and co-design a tailored intervention to strengthen their vaccine uptake (2021-2022). Barriers and facilitators to COVID-19 vaccination, information and communication preferences, and intervention suggestions were explored through qualitative in-depth interviews with Congolese migrants, thematically analysed, and mapped to the theoretical domains framework (TDF) and the Capability, Opportunity, Motivation, Behaviour (COM-B) model to identify target behaviours and strategies to include in interventions. Workshops were done in partnership with Congolese migrants to co-design and tailor interventions. Results 32 Congolese adult migrants (foreign-born and living in UK; 24 (75%) women, mean 14.3 [SD 7.5] years in UK, mean age 52.6 [SD 11.0] years) took part in in-depth interviews and 16 (same sample) took part in co-design workshops. We identified 14 barriers and 10 facilitators to COVID-19 vaccination; most barrier data related to four TDF domains (beliefs about consequences; emotion; social influences; environmental context and resources), and the behavioural diagnosis concluded interventions should target improving psychological capability, reflective and automatic motivations, and social opportunities. Strategies included behaviour change techniques based on education, persuasion, modelling, enablement, and environmental restructuring, which resulted in a co-designed intervention comprising community-led workshops, COVID-19 vaccination plays and posters. Findings and interventions were disseminated through a community celebration event. Conclusions Our study demonstrates how behavioural theory can be applied to co-designing tailored interventions with marginalised migrant communities through a participatory research paradigm to address a range of health issues and inequalities. Future research should build on this empowering approach, with the goal of developing more sensitive vaccination services and interventions which respond to migrant communities’ unique cultural needs and realities. Patient or public contribution Patient and public involvement (PPI) were embedded in the participatory study design and approach. An independent PPI board comprising five adult migrants with lived experience of accessing healthcare in the UK were also consulted at significant points over the course of the study. Practitioner points Research has shown that migrants experience a range of health and vaccination inequalities but are not well included in health research nor the design of interventions to address these. Using community-based participatory methods, we demonstrated that underserved communities, such as migrants, are resilient, resourceful, and use community assets to find real-world solutions to their health needs. Our approach shows how practitioners can adapt and use behavioural theory and design thinking within a participatory research paradigm to meaningfully involve underserved populations in co-designing acceptable and culturally relevant health interventions to address a range of health issues and inequalities.